borderline significantP = 0.060
104 mg/L, P < 0.001), translating into borderline significant superior survival ( P = 0.060 for rs1520220) and reduced treatment-related mortality ( P = 0.050 for rs978458).
104 mg/L, P < 0.001), translating into borderline significant superior survival ( P = 0.060 for rs1520220) and reduced treatment-related mortality ( P = 0.050 for rs978458).
Homozygosity for the high-producer allele of rs978458 ( IGF1 ) was associated with reduced risk of grade III–IV aGvHD in a univariate model with borderline significance (3.0% for the AA vs. 10.8% for the GG/GA genotype, P = 0.063).